CBFCX | RIRGX | CBFCX / RIRGX | |
Total Expense Ratio | 1.59 | 0.27 | 589% |
Annual Report Gross Expense Ratio | 1.59 | 0.27 | 589% |
Fund Existence | 14 years | 16 years | - |
Gain YTD | 6.892 | 10.544 | 65% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 27.3B | 114B | 24% |
Annual Yield % from dividends | 1.14 | 3.35 | 34% |
Returns for 1 year | 4.72 | 14.28 | 33% |
Returns for 3 years | 26.06 | 33.51 | 78% |
Returns for 5 years | 23.82 | 50.25 | 47% |
Returns for 10 years | 40.63 | 48.18 | 84% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HIO | 3.90 | 0.01 | +0.26% |
Western Asset High Income Opportunity Fund | |||
BSJV | 26.31 | -0.05 | -0.20% |
Invesco BulletShares 2031 HY Corp Bd ETF | |||
USIG | 50.71 | -0.23 | -0.45% |
iShares Broad USD Invm Grd Corp Bd ETF | |||
SPLB | 22.10 | -0.21 | -0.94% |
SPDR® Portfolio Long Term Corp Bd ETF | |||
XPH | 41.43 | -0.63 | -1.50% |
SPDR® S&P Pharmaceuticals ETF |